Management of gastro-oesophageal reflux disease in primary care: a European observational study.
OBJECTIVE
To describe the management of gastro-oesophageal reflux disease (GERD) in primary care, as part of the RANGE (Retrospective ANalysis of GERD) study.


METHODS
Over 4 months, at 134 primary care practices in six European countries, 12 815 patients consulted for GERD-related reasons. A random selection of these patients was invited to enter the study. Data were then collected retrospectively (from the initial consultation) and prospectively (from a follow-up visit). This included information on GERD diagnosis, symptoms and complications, medication use and healthcare resource utilisation.


RESULTS
Of 12 815 patients who underwent consultation for GERD-related reasons, 2678 were randomly selected and accepted the invitation to participate in the study. Across countries, 28-47% of patients reported a significant GERD symptom load at initial consultation. Thereafter, 30-100% of patients were prescribed a proton pump inhibitor (PPI), but a significant GERD symptom load was still experienced by 15-30% (all patients combined) at follow-up (median 5.0-7.5 months after initial consultation). In the majority of patients (65-88%), no diagnostic procedures were performed between initial consultation and follow-up. During the follow-up period, the most common form of healthcare utilisation comprised additional GERD-related consultations with a physician.


CONCLUSIONS
The findings of this pan-European study indicate that current management of primary care patients with GERD is far from optimal, and accounts for a marked burden on patients and healthcare systems alike. A more structured approach to GERD management, by tailoring treatment according to the impact of the disease, may reduce this burden.
Gisbert
Javier P
JP
Department of Gastroenterology, Hospital Universitario de la Princesa, C/ Diego de León 62, Madrid, Spain. gisbert@meditex.es
Cooper
Alun
A
Karagiannis
Dimitrios
D
Hatlebakk
Jan
J
Agréus
Lars
L
Jablonowski
Helmut
H
Tafalla
Monica
M
D000328:Adult; D000368:Aged; D000465:Algorithms; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005260:Female; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D006295:Health Resources / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D009819:Office Visits / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care; D012008:Recurrence; D012189:Retrospective Studies
D000897:Anti-Ulcer Agents